The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993

Journal of Rheumatology

Volumn 24, Issue 1, 1997, Pages 73-80

  Peterson, Lynne S ^a,c   Nelson, Audrey M ^a   Su, W P Daniel ^a,d   Mason, Tom ^a,e   O'Fallon, W Michael ^a,e   Gabriel, Sherine E ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

^c UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^e Department of Internal Medicine ^*

Author keywords

epidemiology; localized scleroderma; morphea

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORPHEA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISABILITY EVALUATION; FAMILY HEALTH; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; MINNESOTA; PREVALENCE; SCLERODERMA, LOCALIZED; SURVIVAL RATE; TIME FACTORS;

EID: 0031019554     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Fleishchmajer R, Nedwich A: Generalized morphea. I. Histology of the dermis and subcutaneous tissue. Arch Dermatol 1972;106:509-14.
2. Peterson LS, Nelson AM, Su WPD: Classification of morphea (localized scleroderma). Mayo Clin Proc 1995;70:1068-76.
3. Christianson HB, Dorsey CS, O'Leary PA, Kierland RR: Localized scleroderma: A clinical study of two hundred thirty-five cases. Arch Dermatol 1956;74:629-39.
4. Jablonska S, Rodnan GP: Localized forms of scleroderma. Clin Rheum Dis 1979;5:215-41.
5. Chazen EM, Cook CD, Cohen J: Focal scleroderma. J Pediatr 1962;60:385-93.
6. Hanson V: Dermatomyositis, scleroderma and polyarteritis nodosa. Clin Rheum Dis 1976;2:445-67.
7. Kornreich HK, King KK, Bernstein BH, Singsen BH, Hanson V: Scleroderma in childhood. Arthritis Rheum 1977;20:343-50.
8. Serup J: Clinical appearance of skin lesions and disturbances of pigmentation of localized scleroderma. Acta Derm Venereol 1984;64:485-92.
9. Stogmann W, Sandhofer M, Fritz J: Immunological studies in childhood scleroderma. Eur J Pediatr 1977;124:223-30.
10. Scarola JA, Shulman LE: Serologic abnormalities and their significance in localized scleroderma (abstr). Arthritis Rheum 1975;18:526.
11. Rodnan GP, Lipinski E, Rabin BS, Reichlin M: Eosinophilia and serologic abnormalities in linear localized scleroderma (abstr). Arthritis Rheum 1977;20:133.
12. Tekahara K, Morroi Y, Nakabayashi Y, Ishibashi Y: Antinuclear antibodies in localized scleroderma (abstr). Arthritis Rheum 1983;26:612.
13. Ruffatti A, Peserico A, Glorioso S, et al: Anticentromere antibody in localized scleroderma. J Am Acad Dermatol 1986;15:537-642.
14. Melton LJ: History of the Rochester epidemiology project. Mayo Clin Proc 1986;71:266-74.
15. McCullagh P, Nelder JA: An outline of generalized linear models. In: Cox DR, Hinkley DV, eds. Generalized Linear Models. London: Chapman and Hill, 1983:15-34.
16. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
17. Levinson JE, Bove KE: Scleroderma. In: Gershwin ME, Robbins DL, eds. Musculoskeletal Disease of Children. New York: Grune & Stratton, 1983:195-208.
18. Towner SR, Michet CJ, O'Fallon WM, Nelson AM: The epidemiology of juvenile arthritis in Rochester, Minnesota 1960-1979. Arthritis Rheum 1983;26:1208-13.
19. Silman A, Jannini S, Symmons D, Bacon P: An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988;27:286-90.
20. Uziel Y, Krafchik BR, Feldman B, Silverman ED, Rubin LA, Laxer RM: Serum levels of soluble interleukin-2 receptor: A marker of disease activity in localized scleroderma. Arthritis Rheum 1994;37:898-901.
21. Michet CJ, McKenna CH, Elveback LR, Kaslow RA, Kurland LT: Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-13.
22. Diaz-Perez JL, Connolly SM, Winkelmann RK: Disabling pansclerotic morphea of children. Arch Dermatol 1950;116:169-73.
23. Su WP, Person JR: Morphea profunda: A new concept and a histopathologic study of 23 cases. Am J Dermatopathol 1981;3:251-60.
24. Jablonsak S: Localized scleroderma. In: Jablonska S, ed. Scleroderma and Pseudoscleroderma. Warsaw: Polish Medical Publishers, 1975:277-303.
25. Shulman LE: Diffuse fasciitis with eosinophilia: A new syndrome? Trans Assoc Am Physicians 1975;88:70-86.
26. Hoesly JM, Mertz LE, Winkelmann RK: Localized scleroderma (morphea) and antibody to Borrelia burgdorferi. J Am Acad Dermatol 1987;17:455-8.
27. Aberer E, Klade H, Stanek G, Gebhart W: Borrelia burgdorferi and different types of morphea. Dermatology 1991;182:145-54.
28. Varga J, Uitto J, Jimenez SA: The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Intern Med 1992;116:140-7.
29. Martin RW, Duffy J, Engel AG, et al: The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Ann Intern Med 1990;113:124-34.
30. Dehen L, Roujeau J, Cosnes A, Revuz J: Internal involvement in localized scleroderma. Medicine 1994;73:241-5.
31. Haim S, Sherf K: Scleroderma "en plaque" associated with systemic manifestation. Harefuah 1965;69:172-4.
32. Tuffanelli DL, Marmelzal WL, Dorsey CS: Linear scleroderma with hemiatrophy: Report of three cases associated with collagen-vascular disease. Dermatology 1966;132:51-8.
33. Hoskins LC, Norris HT, Gottlieb LS, Zamcheck N: Function and morphologic alterations of the gastro-intestinal tract in PSS (scleroderma). Am J Med 1962;33:459-70.
34. Ikai K, Tagami H, Imamura S, Hayakawa M: Morphea-like cutaneous changes in a patient with systemic scleroderma. Dermatology 1979;158:438-42.
35. Mayorquin FJ, McCurley TL, Levernier LE, Myers LK, Becker JA, Graham TP: Progression of childhood linear scleroderma to fatal systemic sclerosis. J Rheumatol 1994;21:1955-7.
36. Birdi N, Laxer RM, Thorner P, Fritzler MJ, Silverman ED: Localized scleroderma progressing to systemic disease. Arthritis Rheum 1995;36:410-5.
37. Torok E, Ablonczy E: Morphoea in children. Clin Exp Dermatol 1986;11:607-12.
38. Curtis AC, Jansen TG: The prognosis of localized scleroderma. Arch Dermatol 1958;78:749-57.
39. Leibson CL, Ballard DJ, Whisnant JP, Melton LJ: The compression of morbidity hypothesis: Promise and pitfalls of using record-linked ; data bases to assess secular trends in morbidity and mortality. Milbank Q 1992;70:127-54.